Results 21 to 30 of about 199,939 (188)
Background 18F-FDG PET/CT has proven to be a reliable tool for therapy monitoring in sarcoidosis. Previous PET studies investigated the SUVmax as a marker for disease activity. Total lung glycolysis (TLuG) is a new tool, quantifying the glycolysis of the
Milou C. Schimmelpennink+3 more
doaj +1 more source
Progression of radiographic fibrosis in rheumatoid arthritis-associated interstitial lung disease
Background and objectivesPreclinical interstitial lung disease (pILD) may represent the early stages of rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
Dandan Chai+7 more
doaj +1 more source
The enzyme telomerase reverse transcriptase (TERT) is essential for telomere maintenance. In replicating cells, maintenance of telomere length is important for the preservation of vital genetic information and prevention of genomic instability.
Reinier Snetselaar+5 more
doaj +1 more source
The Role of Cutibacterium acnes in Sarcoidosis: From Antigen to Treatable Trait?
Cutibacterium acnes (C. acnes, formerly Propionibacterium acnes) is considered to be a non-pathogenic resident of the human skin, as well as mucosal surfaces. However, it also has been demonstrated that C.
Raisa Kraaijvanger, Marcel Veltkamp
doaj +1 more source
Diagnostic ability of multidisciplinary discussion in interstitial lung diseases and rare lung diseases [PDF]
The lessons contained herein were learned from a four-year multidisciplinary discussion (MDD) on interstitial lung diseases (ILD). ILDs describe a heterogeneous collection of lung disorders.
Khalifa, Abdelkarim
core
Telomeres in interstitial lung diseases [PDF]
Interstitial lung diseases (ILD) encompass a group of conditions involving fibrosis and/or inflammation of the pulmonary parenchyma. Telomeres are repetitive DNA sequences at chromosome ends which protect against genome instability. At each cell division,
Renzoni, E, Stock, C
core +1 more source
Comorbidities in unclassifiable interstitial lung disease
Background Comorbidities are common in interstitial lung diseases (ILD) and have an important association with survival, but the frequency and prognostic impact of comorbidities in unclassifiable interstitial lung disease (uILD) remains elusive. We aimed
Thomas Skovhus Prior+6 more
doaj +1 more source
Background: There is insufficient information in the literature on the comparative efficacy and tolerability of methotrexate (MTX) and methylprednisolone (MP) in patients with pulmonary sarcoidosis in assessing primary outcomes and the relapse rate ...
Volodymyr Gavrysyuk+6 more
doaj +1 more source
Diffuse Alveolar Damage: A Common Phenomenon in Progressive Interstitial Lung Disorders [PDF]
It has become obvious that several interstitial lung diseases, and even viral lung infections, can progress rapidly, and exhibit similar features in their lung morphology.
Kaarteenaho, Riitta, Kinnula, Vuokko L.
core +4 more sources
Desaturation – distance ratio: a new concept for a functional assessment of interstitial lung diseases [PDF]
INTRODUCTION: The functional evaluation has become increasingly important in the understanding and management of patients with interstitial lung diseases.
Baldi, Bruno Guedes+5 more
core +5 more sources